Instead, they reduce water retention indirectly by decreasing body weight, lowering insulin resistance, and improving metabolic function
Unlike older single-mechanism weight loss drugs, Retatrutide is engineered as a triagonist meaning it simultaneously activates three key metabolic receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors
Clinical trials show the medications produce significantly higher weight reduction than lifestyle interventions alone
Focus areas: Establish hydration habits now, before higher doses make GI symptoms more pronounced Track protein intake for at least one week to establish a baseline Begin or maintain light exercise (walking 20 to 30 minutes daily) Get bloodwork done if you do not have recent results (ferritin, B12, vitamin D, metabolic panel) Start an electrolyte supplement if experiencing any nausea or GI symptoms The goal at this stage is building habits that will protect you at higher doses
Zepbound (for weight management and obstructive sleep apnea) and Mounjaro (for type 2 diabetes) are both made by Eli Lilly, FDA-approved, and tested for purity, strength, and sterility
However, the antioxidant benefit of SELENOP can be obscured under conditions of reductive stress [246]